Protalix BioTherapeutics Inc.

ASE:PLX   3:59:40 PM EDT
-0.08 (-2.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)131.62M
Current PEN/A
Forward PE N/A
2yr Forward PE 8.29
See more stats
Estimates Current Quarter
Revenue$16.1 Million
Adjusted EPS-$0.02
See more estimates
10-Day MA$3.29
50-Day MA$4.68
200-Day MA$4.08
See more pivots

Protalix BioTherapeutics Inc. Stock, ASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.696.9345
Number of Employees: 207


Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.